|
|
||||||||
J Thorac Cardiovasc Surg 1996;112:1399-1400
© 1996 Mosby, Inc.
BRIEF COMMUNICATIONS |
Baltimore, Md., and Ann Arbor, Mich.
Received for publication Jan. 22, 1996 Accepted for publication Feb. 2, 1996.
Arterial monitoring is essential for the perioperative treatment of children undergoing repair of congenital cardiac defects. Peripheral arterial cannulation in small children can be difficult, and catheter-related complications are common.
1 For these reasons, femoral arterial cannulation is frequently performed. According to clinical criteria, the incidence of femoral artery complications (ischemia, thrombosis, embolism, and infection) after cannulation in children is between 0.1% and 14%.
2 Clinical criteria are known to be insensitive, however, in the diagnosis of femoral artery obstruction in children.
3-5 Ultrasonography has been shown to be sensitive and specific for the diagnosis of femoral artery obstruction. By means of ultrasonography, we recently demonstrated a 33% incidence of femoral artery obstruction among infants after cardiac catheterization
3 and a 26% prevalence among children undergoing transfemoral arterial balloon angioplasty or valvuloplasty.
4 The purposes of this study were to prospectively determine the prevalence of and predictors for complications of femoral artery cannulation for perioperative monitoring in children.
Thirty consecutive children with a mean age of 19 ± 7 months (median 5.3 months, range 1 day to 13 years) were entered prospectively into this study after femoral artery cannulation for perioperative arterial monitoring. The children's mean weight was 9.5 ± 2.4 kg (median 5.4 kg). Ten patients underwent palliative operations (including hemi-Fontan or Fontan operations); 20 underwent corrective operations. In the operating room, the femoral artery was cannulated percutaneously in 24 patients and by cutdown in six patients with a 22 gauge 1.38-inch polyurethane catheter (Arrow International, Inc., Reading, Pa.). Heparinized fluid was infused through the catheters. The femoral arteries were cannulated for 6.9 ± 1.5 days (median 4 days, range 0.5 to 35 days). Indications for catheter removal and catheter complications, as diagnosed by clinical criteria (ischemia, peripheral embolism, hemorrhage, infection, and other), were recorded. Both femoral arteries were evaluated with ultrasonography 3.5 ± 0.4 days (range 0 to 11 days) after catheter removal. Femoral artery obstruction was diagnosed according to previously described criteria.
3 The demographic and clinical data (age, weight, height, diagnosis, type of operation [palliative or corrective], previous cardiac catheterization, previous femoral artery cannulation, insertion technique [percutaneous or surgical cutdown], and duration of arterial cannulation) were collected, combined with outcome measures (clinical complications and ultrasonographic results), and analyzed with univariate and multivariate logistic regression modeling techniques.
Clinically, two (7%, 95% confidence interval 0% to 16%) femoral artery complications occurred
(Table I, patients 1 and 2). By means of ultrasonography, six patients (20%) were found to have complete obstruction of the cannulated femoral artery and one (3%) was found to have partial obstruction (95% confidence interval 8% to 38%;
Table I, patients 3 through 9). All of these patients had no clinical symptoms. No statistically significant predictors of femoral artery complications were identified.
|
It is well known that clinical criteria are insensitive in diagnosing femoral artery obstruction in children.
3-5 For this reason, we used ultrasonography to examine the femoral artery in children. We had found that 32% of infants undergoing cardiac catheterization had complete femoral artery obstruction, and many of these had no clinical signs or symptoms.
3 We had also reported that 26% of a select group of symptom-free children who underwent transfemoral arterial balloon angioplasty or valvuloplasty had complete femoral artery obstruction.
4 In the current study, 20% of patients had complete femoral artery obstruction and 3% partial femoral artery obstruction diagnosed by ultrasonography after cannulation. The long-term significance of femoral artery obstruction in children without symptoms is unknown, and further studies are necessary.
The second purpose of this study was to determine predictors for femoral artery complications after cannulation. Previous authors
2 have identified neonatal status, age younger than 5 years, and weight less than 10 kg as predictors of femoral artery complications, but none of these were so identified in this study.
Advantages of femoral artery catheters are the relative ease of insertion in infants and children, low incidence of complications, and pressure recordings that in certain clinical settings more accurately reflect true aortic pressure than do peripheral artery recordings. This last factor can be clinically significant when attempting to discontinue cardiopulmonary bypass after complex surgical repairs, when the proximal artery is crossclamped during the operative procedure (e.g., modified Blalock-Taussig shunt), or in situations in which peripheral vascular resistance is markedly increased (e.g., cardiogenic shock or infusion of vasoconstricting agents). Except in these clinical settings, our practice is to percutaneously cannulate the radial artery. If this is unsuccessful, the femoral artery is percutaneously cannulated. Finally, in some cases we prefer to proceed to radial artery cutdown rather than cannulating the femoral artery, as for patients in whom repeated cardiac catheterization through the femoral artery is anticipated (e.g., those with hypoplastic left heart syndrome).
The incidence of clinically detectable complications of femoral artery cannulation after perioperative monitoring in children was 7%, and all resolved with catheter removal. Ultrasonography was used to detect asymptomatic femoral artery obstruction in 23% of patients. No statistically significant predictors for femoral artery complications were found.
Acknowledgments
We thank Daniel J. Kocis, Jr., PhD, for his assistance with the statistical analyses.
Footnotes
From the Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore,a and Departments of Pediatricsb and Surgery,c University of Michigan Medical Center, Ann Arbor, Mich. ![]()
J THORAC CARDIOVASC SURG 1996;112:1399-1400 ![]()
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |